[Economic and epidemiologic aspects of generalized anxiety disorder: a review of the literature]
- PMID: 18478457
[Economic and epidemiologic aspects of generalized anxiety disorder: a review of the literature]
Abstract
Introduction: The objective is to assess the prevalence and treatment patterns of generalized anxiety disorder (GAD) in Spain as well as the cost associated to this disorder in different countries.
Methods: A search in the literature of health and economics databases was conducted.
Results: In regards to the 32 references selected, 6 studies had data on the prevalence of GAD and 3 on treatment patterns in Spain and 11 studies on the costs associated to the disease on an international level. The remaining 20 studies were of general interest for methodological or contextual reasons.
Conclusions: GAD is a mental disorder with high prevalence. According to some authors, it is probably underdiagnosed. No appropriate long term treatment is available. High health care and social costs are associated to GAD. The frequent presence of comorbidity, different definitions and methodologies used in the studies limits the comparability and synthesis of the results. It also makes it difficult to obtain valid estimations of prevalence and costs.
Similar articles
-
Human and economic burden of generalized anxiety disorder.Depress Anxiety. 2008;25(1):72-90. doi: 10.1002/da.20257. Depress Anxiety. 2008. PMID: 17146763 Review.
-
Patterns and correlates of generalized anxiety disorder in community samples.J Clin Psychiatry. 2002;63 Suppl 8:4-10. J Clin Psychiatry. 2002. PMID: 12044107 Review.
-
Generalized anxiety disorder: prevalence, burden, and cost to society.Depress Anxiety. 2002;16(4):162-71. doi: 10.1002/da.10065. Depress Anxiety. 2002. PMID: 12497648
-
The cost of treating anxiety: the medical and demographic correlates that impact total medical costs.Depress Anxiety. 2005;21(4):178-84. doi: 10.1002/da.20074. Depress Anxiety. 2005. PMID: 16075454
-
The epidemiology of generalized anxiety disorder in Europe.Eur Neuropsychopharmacol. 2005 Aug;15(4):445-52. doi: 10.1016/j.euroneuro.2005.04.010. Eur Neuropsychopharmacol. 2005. PMID: 15951160 Review.
Cited by
-
Diagnosis of Anxiety in COPD Patients: Usefulness of the HADS Test in Primary Care and Pulmonology Services.J Pers Med. 2024 Jul 2;14(7):713. doi: 10.3390/jpm14070713. J Pers Med. 2024. PMID: 39063967 Free PMC article.
-
[Cumulative incidence, comorbility and disability for anxiety disorders in patients of a mutual worker accident.].Rev Esp Salud Publica. 2019 Oct 10;93:e201910068. Rev Esp Salud Publica. 2019. PMID: 31597911 Free PMC article. Spanish.
-
Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors.Ann Gen Psychiatry. 2015 Jan 22;14(1):2. doi: 10.1186/s12991-014-0040-0. eCollection 2015. Ann Gen Psychiatry. 2015. PMID: 25632294 Free PMC article.